Last reviewed · How we verify
HUC2-344-R1, HUC2-344-R2
HUC2-344-R1, HUC2-344-R2 is a Small molecule drug developed by Huons Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | HUC2-344-R1, HUC2-344-R2 |
|---|---|
| Sponsor | Huons Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1 Study in Diabetes Mellitus(Fed) (PHASE1)
- Phase 1 Study in Diabetes Mellitus(Fasting) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HUC2-344-R1, HUC2-344-R2 CI brief — competitive landscape report
- HUC2-344-R1, HUC2-344-R2 updates RSS · CI watch RSS
- Huons Co., Ltd. portfolio CI
Frequently asked questions about HUC2-344-R1, HUC2-344-R2
What is HUC2-344-R1, HUC2-344-R2?
HUC2-344-R1, HUC2-344-R2 is a Small molecule drug developed by Huons Co., Ltd..
Who makes HUC2-344-R1, HUC2-344-R2?
HUC2-344-R1, HUC2-344-R2 is developed by Huons Co., Ltd. (see full Huons Co., Ltd. pipeline at /company/huons-co-ltd).
What development phase is HUC2-344-R1, HUC2-344-R2 in?
HUC2-344-R1, HUC2-344-R2 is in Phase 1.
Related
- Manufacturer: Huons Co., Ltd. — full pipeline
- Compare: HUC2-344-R1, HUC2-344-R2 vs similar drugs
- Pricing: HUC2-344-R1, HUC2-344-R2 cost, discount & access